269 related articles for article (PubMed ID: 36621176)
1. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
Lopez-Pedrera C; Patiño-Trives AM; Cerdó T; Ortega-Castro R; Sanchez-Pareja I; Ibañez-Costa A; Muñoz-Barrera L; Ábalos-Aguilera MC; Ruiz-Vilchez D; Seguí Azpilcueta P; Espinosa M; Barbarroja N; Escudero-Contreras A; Castaño JP; Luque RM; Ortega R; Aguirre MA; Perez-Sanchez C
J Autoimmun; 2023 Feb; 135():102990. PubMed ID: 36621176
[TBL] [Abstract][Full Text] [Related]
2. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
[TBL] [Abstract][Full Text] [Related]
3. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Reshetnyak T; Nurbaeva K; Ptashnik I; Kudriaeva A; Belogurov A; Lila A; Nasonov E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298160
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
[TBL] [Abstract][Full Text] [Related]
5. Pauci-immune Lupus Nephritis in Antiphospholipid Disease: A Diagnostic Challenge.
Alhemyadi SA; Al-Hamidi AA; Asiri S; Al-Swailem R
Saudi J Kidney Dis Transpl; 2022; 33(1):196-200. PubMed ID: 36647996
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid Syndrome and the Kidney.
Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of allelic variants affecting the hemostatic system in the development of antiphospholipid syndrome and kidney lesion in patients with systemic lupus erythematosus].
Borisov EN; Krasnova TN; Samohodskaia LM; Ivanitskiĭ LV; Nikiforova NV; Mukhin NA
Ter Arkh; 2014; 86(6):57-62. PubMed ID: 25095657
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
Wirestam L; Arve S; Linge P; Bengtsson AA
Front Immunol; 2019; 10():2734. PubMed ID: 31824510
[TBL] [Abstract][Full Text] [Related]
10. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
Zdrojewski Z
Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
[TBL] [Abstract][Full Text] [Related]
11. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
12. Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.
van den Hoogen LL; van Roon JAG; Mertens JS; Wienke J; Lopes AP; de Jager W; Rossato M; Pandit A; Wichers CGK; van Wijk F; Fritsch-Stork RDE; Radstake TRDJ
Ann Rheum Dis; 2018 Dec; 77(12):1810-1814. PubMed ID: 30185417
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.
Lin Z; Liu Y; Chen L; Cao S; Huang Y; Yang X; Zhu F; Tang W; He S; Zuo J
Sci China Life Sci; 2021 Oct; 64(10):1702-1719. PubMed ID: 33481164
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
Kotzen ES; Roy S; Jain K
Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
[TBL] [Abstract][Full Text] [Related]
18. [Systemic lupus erythematosus and antiphospholipid syndrome].
Gröne HJ
Verh Dtsch Ges Pathol; 1996; 80():21-37. PubMed ID: 9065004
[TBL] [Abstract][Full Text] [Related]
19. Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus.
Wang J; Guo HX; Cheng T; Shi L; Zhang SX; Li XF
Lupus; 2023 May; 32(6):746-755. PubMed ID: 37051771
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential biomarkers for systemic lupus erythematosus by integrated analysis of gene expression and methylation data.
Zhang W; Liang G; Zhou H; Zeng X; Zhang Z; Xu X; Lai K
Clin Rheumatol; 2023 May; 42(5):1423-1433. PubMed ID: 36595110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
